Close Menu
Home › FIND Joins CARB-X to Support Development of Diagnostics to Combat Antimicrobial Resistance

FIND Joins CARB-X to Support Development of Diagnostics to Combat Antimicrobial Resistance

Feb 26, 2019

NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics (FIND) is joining the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Global Accelerator Network, the organizations announced today.

The CARB-X Global Accelerator Network now includes 10 organizations that provide business, scientific, and technical expertise and services to CARB-X-funded companies to support their antibacterial research projects.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Infectious Disease

  1. Roche Reports Flat Q1 Diagnostics Sales

  2. Cepheid Outlines Assay Improvements, Xpert Cartridge Partnering Program at ECCMID

    Premium

  3. Beckman Coulter Early Sepsis Indicator Granted FDA Clearance

  4. Oxford Nanopore Sequencing Shows Promise for Diagnosing Prosthetic Joint Infections

    Premium

  5. GenMark Diagnostics Obtains FDA Clearance for Gram-Negative Sepsis Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.